METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPY
收藏国家林业和草原科学数据中心2023-02-12 更新2024-03-07 收录
下载链接：
https://www.forestdata.cn/dataDetail.html?id=866f71a5-6b35-426e-914a-104ffab6b2f9
下载链接
链接失效反馈官方服务：
资源简介：
The present invention relates to methods for developing engineered T-cells for immunotherapy that are non-alloreactive. The present invention relates to methods for modifying T-cells by inactivating both genes encoding T-cell receptor and an immune checkpoint gene to unleash the potential of the immune response. This method involves the use of specific rare cutting endonucleases， in particular TALE-nucleases (TAL effector endonuclease) and polynucleotides encoding such polypeptides， to precisely target a selection of key genes in T-cells， which are available from donors or from culture of primary cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies for treating cancer and viral infections. The present invention relates to methods for developing engineered T-cells for immunotherapy that are non-alloreactive. The present invention relates to methods for modifying T-cells by inactivating both genes encoding T-cell receptor and an immune checkpoint gene to unleash the potential of the immune response. This method involves the use of specific rare cutting endonucleases， in particular TALE-nucleases (TAL effector endonuclease) and polynucleotides encoding such polypeptides， to precisely target a selection of key genes in T-cells， which are available from donors or from culture of primary cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies for treating cancer and viral infections.
提供机构：
国家林业和草原科学数据中心
创建时间：
2023-02-12
